Evaluation of Leishmania infantum 30x biotherapy effects in the prevention and treatment of visceral leishmaniasis: in vivo and in vitro studies
Background: Leishmaniasis is a serious public health problem especially in developing countries [1]. The therapeutic potential of biotherapics against several microorganism has been described in vitro [2,3] and in vivo studies [4,5,6,7,8,9]. Considering the resistance of leishmaniasis to conventiona...
Saved in:
Published in | International journal of high dilution research Vol. 15; no. 4; pp. 26 - 29 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
18.08.2021
|
Online Access | Get full text |
Cover
Loading…
Abstract | Background:
Leishmaniasis is a serious public health problem especially in developing countries [1]. The therapeutic potential of biotherapics against several microorganism has been described in vitro [2,3] and in vivo studies [4,5,6,7,8,9]. Considering the resistance of leishmaniasis to conventional treatment as well as previous studies with biotherapic, we evaluated the effects of Leishmania infantum 30x (BioLi30x) biotherapy.
Aim: evaluate the antileishmanial effects of BioLi30x in in vivo and in vitro models.
Methodology:
The in vivo experiments were performed using BALB/c mice (n=138), divided into 8 groups: G1-healthy, G2-infected with L. infantum, G3-BioLi30x pre-treated, G4-BioLi30x pre/post-treated, G5-BioLi30x post-treated, G6-H2O30x post-treated, G7-Antimonium crudum 30x post-treated and G8-Glucantime® post-treated. After 49 days of treatment, the animals were submitted to euthanasia (ethical approval ECUA/UFRJ/066/14). Liver and spleen histological changes were evaluated, and serum samples were aliquoted and storage at -20°C for cytokine assays. The in vitro assays were performed using RAW 264.7 macrophages treated with BioLi30x and infected with L. infantum. The morphological aspects were evaluated by scanning electron microscopy (SEM), and the nitric oxide (NO) release was quantified in the supernatant of infected macrophages.
Results:
The histological analysis from 4 independent experiments showed livers with normal appearance (G1); periportal chronic hepatitis (G2,G4,G5,G8); discreet (G3,G7), moderate (G4,G5,G6), and severe (G2,G8) vacuolar hydropic degeneration; congestion and neutrophilic inflammation (G2,G4,G5,G6,G8), and possible amastigotes within macrophages (G2-G8). Spleens presented healthy appearance only in G1. All treated animals presented histological alterations, with different lesions severity, which involved spleen pulp hyperplasia with moderate disruption (G2,G8), as well as megakaryocytes and macrophages proliferation (G2- G8). SEM analyses showed BioLi30x treatments induced significant protozoan morphology alterations when compared to H2O30x. Besides, a 19% increase in the NO release was detected in RAW supernatants, when compared to H2O30x.
Conclusions:
BioLi30x and Antimonium crudum 30x modified the infection animal process, involving several cellular mechanisms as well as different histological damage. The in vitro experiments will be repeated in order to confirm these preliminary results. |
---|---|
AbstractList | Background:
Leishmaniasis is a serious public health problem especially in developing countries [1]. The therapeutic potential of biotherapics against several microorganism has been described in vitro [2,3] and in vivo studies [4,5,6,7,8,9]. Considering the resistance of leishmaniasis to conventional treatment as well as previous studies with biotherapic, we evaluated the effects of Leishmania infantum 30x (BioLi30x) biotherapy.
Aim: evaluate the antileishmanial effects of BioLi30x in in vivo and in vitro models.
Methodology:
The in vivo experiments were performed using BALB/c mice (n=138), divided into 8 groups: G1-healthy, G2-infected with L. infantum, G3-BioLi30x pre-treated, G4-BioLi30x pre/post-treated, G5-BioLi30x post-treated, G6-H2O30x post-treated, G7-Antimonium crudum 30x post-treated and G8-Glucantime® post-treated. After 49 days of treatment, the animals were submitted to euthanasia (ethical approval ECUA/UFRJ/066/14). Liver and spleen histological changes were evaluated, and serum samples were aliquoted and storage at -20°C for cytokine assays. The in vitro assays were performed using RAW 264.7 macrophages treated with BioLi30x and infected with L. infantum. The morphological aspects were evaluated by scanning electron microscopy (SEM), and the nitric oxide (NO) release was quantified in the supernatant of infected macrophages.
Results:
The histological analysis from 4 independent experiments showed livers with normal appearance (G1); periportal chronic hepatitis (G2,G4,G5,G8); discreet (G3,G7), moderate (G4,G5,G6), and severe (G2,G8) vacuolar hydropic degeneration; congestion and neutrophilic inflammation (G2,G4,G5,G6,G8), and possible amastigotes within macrophages (G2-G8). Spleens presented healthy appearance only in G1. All treated animals presented histological alterations, with different lesions severity, which involved spleen pulp hyperplasia with moderate disruption (G2,G8), as well as megakaryocytes and macrophages proliferation (G2- G8). SEM analyses showed BioLi30x treatments induced significant protozoan morphology alterations when compared to H2O30x. Besides, a 19% increase in the NO release was detected in RAW supernatants, when compared to H2O30x.
Conclusions:
BioLi30x and Antimonium crudum 30x modified the infection animal process, involving several cellular mechanisms as well as different histological damage. The in vitro experiments will be repeated in order to confirm these preliminary results. |
Author | Goma, Ester Puna Puna Dos Santos, Hilton Antônio Mata Holandino, Carla Buchi, Dorly de Freitas Rodrigues, Igor Almeida Cajueiro, Ana Paula Bacellar Gomes, Nelson Brêtas de Noronha Toma, Helena Keiko Matos, Ana Paula dos Santos Araújo, Silvana Marques Castelo-Branco, Morgana Teixeira Oliveira, Adriana Passos Homsani, Fortune Pyrrho, Alexandre dos Santos Barbosa, Gleyce Moreno Bonamin, Leoni Villano Do Nascimento, Katia Fialho |
Author_xml | – sequence: 1 givenname: Ana Paula Bacellar surname: Cajueiro fullname: Cajueiro, Ana Paula Bacellar – sequence: 2 givenname: Gleyce Moreno surname: Barbosa fullname: Barbosa, Gleyce Moreno – sequence: 3 givenname: Fortune surname: Homsani fullname: Homsani, Fortune – sequence: 4 givenname: Ana Paula dos Santos surname: Matos fullname: Matos, Ana Paula dos Santos – sequence: 5 givenname: Igor Almeida surname: Rodrigues fullname: Rodrigues, Igor Almeida – sequence: 6 givenname: Leoni Villano surname: Bonamin fullname: Bonamin, Leoni Villano – sequence: 7 givenname: Silvana Marques surname: Araújo fullname: Araújo, Silvana Marques – sequence: 8 givenname: Katia Fialho surname: Do Nascimento fullname: Do Nascimento, Katia Fialho – sequence: 9 givenname: Dorly de Freitas surname: Buchi fullname: Buchi, Dorly de Freitas – sequence: 10 givenname: Nelson Brêtas de Noronha surname: Gomes fullname: Gomes, Nelson Brêtas de Noronha – sequence: 11 givenname: Ester Puna Puna surname: Goma fullname: Goma, Ester Puna Puna – sequence: 12 givenname: Hilton Antônio Mata surname: Dos Santos fullname: Dos Santos, Hilton Antônio Mata – sequence: 13 givenname: Morgana Teixeira surname: Castelo-Branco fullname: Castelo-Branco, Morgana Teixeira – sequence: 14 givenname: Helena Keiko surname: Toma fullname: Toma, Helena Keiko – sequence: 15 givenname: Adriana Passos surname: Oliveira fullname: Oliveira, Adriana Passos – sequence: 16 givenname: Alexandre dos Santos surname: Pyrrho fullname: Pyrrho, Alexandre dos Santos – sequence: 17 givenname: Carla surname: Holandino fullname: Holandino, Carla |
BookMark | eNpNkEFOwzAQRS1UJErpnqUvkOKJ42TCDlWFIlVi033kJLbqKrEr243oLTgyaUCI2czoj95fvHsys84qQh6BrQSUwJ7M8dD61QDCZCsUeEPmUGKa5CnLZ__uO7IM4cjG4ZAJwDn52gyyO8tonKVO050y4dBLayQ1Vksbzz3l7JPWxsWD8vJ0oUpr1cQw_ukY0ZNXg7ITL21Lo1cy9mNwbRtMaEaoo91fbTDh-YoOZnATMN3ROxriuTUqPJBbLbuglr97Qfavm_16m-w-3t7XL7ukQcQkxxYZy9KagywL3kKTCo5FUYNGxsuWCWAtclSZhrIErAVPsdF1nkFRlJngC8J-ahvvQvBKVydveukvFbBqclpNTqvJaTU65d9oaG98 |
CitedBy_id | crossref_primary_10_1055_s_0040_1713361 |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.51910/ijhdr.v15i4.858 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1982-6206 |
EndPage | 29 |
ExternalDocumentID | 10_51910_ijhdr_v15i4_858 |
GroupedDBID | 29J 2WC 5GY 5VS 91A AAYXX ABDBF ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL CITATION DIK ESX GROUPED_DOAJ KQ8 KWQ M~E OK1 P6G TR2 TUS |
ID | FETCH-LOGICAL-c888-68d80042b31a973d1c253877b1f8039d0510d838e4f19918b5328cfb641779453 |
ISSN | 1982-6206 |
IngestDate | Fri Aug 23 01:28:38 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c888-68d80042b31a973d1c253877b1f8039d0510d838e4f19918b5328cfb641779453 |
PageCount | 4 |
ParticipantIDs | crossref_primary_10_51910_ijhdr_v15i4_858 |
PublicationCentury | 2000 |
PublicationDate | 2021-08-18 |
PublicationDateYYYYMMDD | 2021-08-18 |
PublicationDate_xml | – month: 08 year: 2021 text: 2021-08-18 day: 18 |
PublicationDecade | 2020 |
PublicationTitle | International journal of high dilution research |
PublicationYear | 2021 |
SSID | ssj0000314518 |
Score | 2.2249327 |
Snippet | Background:
Leishmaniasis is a serious public health problem especially in developing countries [1]. The therapeutic potential of biotherapics against several... |
SourceID | crossref |
SourceType | Aggregation Database |
StartPage | 26 |
Title | Evaluation of Leishmania infantum 30x biotherapy effects in the prevention and treatment of visceral leishmaniasis: in vivo and in vitro studies |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZ-rKXsXUbu6OHURius_hu961pm5XBRmEZ9M1IvlCH1S6xHZb9iv3hws6RZckJHax7MUKJD4nOx9HR0adPhLz3GeTYMA2Z3Mod04WFssm9KTOtgAcuR0U3cQ_Zl6_--Xf386V3ORrdDlhLbcMnya87z5X8j1ehD_yKp2Tv4VllFDqgDf6FJ3gYnv_k4zMl1S1K_VlRX6GcBUOKFYxYe204058GL-Qpq41ib0hy443Ub5KMZE06r3DHvk6wXmX8UGbrQvDn4OV1sa6kbhO0m1UlZGp7PuJSs-N1sXEgUYESyUZadCNjSLkhVZY-Ycs2K-Txm5IJ7iIzZgy3GJiiEuM-SVWLzPcTxDURnVZZWSmYVtd1d12VMYcVRlsOOL5NRy3UxtOqNr7hbcpbRRBbVHW34nYECwXfnkpV7Tv6-mDvDUDtDiO3P8gBuiLM7uwCya6FfMxieZWuJmvLK9xJ2AnPbwt570ywivYICy5hIxYWYmEhBgsPyJ4dRF4wJnvHs9PZXBUJ8W4BT9So1Z_pttqFmY87P2SQWg1ypMVj8kgubuhxh9QnZJSV--TgolNH3xzShT7sVx_SA3qhddM3T8lvDWda5VTDmfZwpgBnquFMJZzhcwpdVMOZAjapgjNa6-FMt-B8hK8imMULog1gphLMz8hifrY4OTflhSFmEkJo8MM0xEmIOxaLAie1Ehum8yCAMBROnSjF-ScNnTBzcyT8hdxz7DDJue9aAUxLnvOcjMuqzF4Qmvsui3IY7ijBO9kjZucJx9oATyF7YPwl-dAPdXzTycLEf_Puq3t89zV5qOH9hoybVZu9hay34e8kNv4A1D63sg |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+Leishmania+infantum+30x+biotherapy+effects+in+the+prevention+and+treatment+of+visceral+leishmaniasis%3A+in+vivo+and+in+vitro+studies&rft.jtitle=International+journal+of+high+dilution+research&rft.au=Cajueiro%2C+Ana+Paula+Bacellar&rft.au=Barbosa%2C+Gleyce+Moreno&rft.au=Homsani%2C+Fortune&rft.au=Matos%2C+Ana+Paula+dos+Santos&rft.date=2021-08-18&rft.issn=1982-6206&rft.eissn=1982-6206&rft.volume=15&rft.issue=4&rft.spage=26&rft.epage=29&rft_id=info:doi/10.51910%2Fijhdr.v15i4.858&rft.externalDBID=n%2Fa&rft.externalDocID=10_51910_ijhdr_v15i4_858 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1982-6206&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1982-6206&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1982-6206&client=summon |